Corrigendum to From Vision to Validation: The Journey of Tofersen in Superoxide Dismutase 1Gene–Associated Amyotrophic Lateral Sclerosis [Mayo Clinic Proceeding: Innovations, Quality & Outcomes 10(5) (2026) PIQO_100755]

Author unknown

Open source

DOI
10.1016/j.mayocpiqo.2026.100775
Published
2026-12
Container
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.mayocpiqo.2026.100775,
  title = {Corrigendum to From Vision to Validation: The Journey of Tofersen in Superoxide Dismutase 1Gene–Associated Amyotrophic Lateral Sclerosis [Mayo Clinic Proceeding: Innovations, Quality \& Outcomes 10(5) (2026) PIQO\_100755]},
  year = {2026},
  journal = {Mayo Clinic Proceedings: Innovations, Quality \& Outcomes},
  doi = {10.1016/j.mayocpiqo.2026.100775},
  url = {https://doi.org/10.1016/j.mayocpiqo.2026.100775}
}

RIS

TY  - JOUR
TI  - Corrigendum to From Vision to Validation: The Journey of Tofersen in Superoxide Dismutase 1Gene–Associated Amyotrophic Lateral Sclerosis [Mayo Clinic Proceeding: Innovations, Quality & Outcomes 10(5) (2026) PIQO_100755]
PY  - 2026
JO  - Mayo Clinic Proceedings: Innovations, Quality & Outcomes
DO  - 10.1016/j.mayocpiqo.2026.100775
UR  - https://doi.org/10.1016/j.mayocpiqo.2026.100775
ER  - 

APA

Corrigendum to From Vision to Validation: The Journey of Tofersen in Superoxide Dismutase 1Gene–Associated Amyotrophic Lateral Sclerosis [Mayo Clinic Proceeding: Innovations, Quality & Outcomes 10(5) (2026) PIQO_100755]. (2026). Mayo Clinic Proceedings: Innovations, Quality & Outcomes. https://doi.org/10.1016/j.mayocpiqo.2026.100775

Source records